BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21369744)

  • 1. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.
    Kneuertz PJ; Patel SH; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
    Ann Surg Oncol; 2011 May; 18(5):1327-34. PubMed ID: 21369744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based on RECIST guidelines.
    Motoi F; Rikiyama T; Katayose Y; Egawa S; Unno M
    Ann Surg Oncol; 2011 Feb; 18(2):371-9. PubMed ID: 20842460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of improving survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
    Shukla PJ
    Ann Surg; 2011 Aug; 254(2):385-6; author reply 386. PubMed ID: 21677560
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas.
    Shimada K; Nara S; Esaki M; Sakamoto Y; Kosuge T; Hiraoka N
    Pancreas; 2011 Apr; 40(3):464-8. PubMed ID: 21289526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
    Abe T; Amano H; Hanada K; Minami T; Yonehara S; Hattori M; Kobayashi T; Fukuda T; Nakahara M; Ohdan H; Noriyuki T
    Anticancer Res; 2017 Oct; 37(10):5863-5870. PubMed ID: 28982913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
    Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
    Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.
    Nagai S; Fujii T; Kodera Y; Kanda M; Sahin TT; Kanzaki A; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Jan; 40(1):3-9. PubMed ID: 20881897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection.
    Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iida T; Iwase R; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4041-7. PubMed ID: 24023348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM; Zhang S; Leiby BE; Pequignot EC; Xia B; Rosato E; Lavu H; Kennedy EP; Yeo CJ; Berger AC
    J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of blood transfusion free pancreaticoduodenectomy to transfusion-eligible pancreaticoduodenectomy.
    Choi YY; Seo D; Choi D; Kim JH; Lee KJ; Ok SY
    Am Surg; 2011 Jan; 77(1):81-7. PubMed ID: 21396312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?
    Santi I; Brandt A; Hemminki K
    Ann Surg Oncol; 2011 Jan; 18(1):300-1. PubMed ID: 20589435
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.